FINSTERER, J. Rhabdomyolysis, renal failure, and visual loss under BRAF/MEK inhibitors trametinib and dabrafenib. Revista Médica de Chile, [S. l.], v. 148, n. 11, 2020. Disponível em: https://www.revistamedicadechile.cl/index.php/rmedica/article/view/7796. Acesso em: 8 jun. 2025.